GRAIL Inc. (GRAL)
NASDAQ·Healthcare·Biotechnology
$71.20
+1.32%
Mkt Cap $2.76B
Analyst Ratings
Buy
4
Hold
3
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
Implied Upside
+4.5%
Consensus $74.43 vs current $71.20
NASDAQ·Healthcare·Biotechnology
$71.20
+1.32%
Mkt Cap $2.76B
Buy
4
Hold
3
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
+4.5%
Consensus $74.43 vs current $71.20